David P Cardin, 5526 Fairview Ave, Wilmington, MA 01887

8183240, May 22, 2012

Jun 17, 2009

12/456455

David P. Cardin - Wilmington MA, US
Paul Greenspan - Acton MA, US
Stepan Vyskocil - Arlington MA, US
Jeffrey Gaulin - Rockingham NH, US
Tianlin Xu - Shrewsbury MA, US
Christelle C. Renou - Stoneham MA, US

Millennium Pharmaceuticals, Inc. - Cambridge MA

A61K 31/535
C07D 413/14

5142358, 544139

This invention provides compounds of formula I:.

8440664, May 14, 2013

Apr 18, 2012

13/449341

David P. Cardin - Wilmington MA, US
Jeffrey Gaulin - Rockingham NH, US
Paul Greenspan - Acton MA, US
Christelle C. Renou - Stoneham MA, US
Stepan Vyskocil - Arlington MA, US
Tianlin Xu - Shrewsbury MA, US

Millennium Pharmaceuticals, Inc. - Cambridge MA

A61K 31/535

5142358

This invention provides compounds of formula I:.

2003019, Oct 16, 2003

Apr 11, 2002

10/122696

Daniel Byron - Marlborough MA, US
Howard Ngai - Southborough MA, US
David Cardin - Stoneham MA, US
Milton Fernandes - Marlborough MA, US

ADC Broadband Access Systems, Inc.

G06F015/173

709/224000, 714/045000

A process for selecting for analysis data units from multiple threads of traffic through a single data switch is provided. The process includes capturing all data units of one thread of traffic when said thread is selected by a system administrator, encapsulating data units matching first criteria with identification and forwarding information, and triggering on said captured data units according to second criteria selectable during said process. The process further includes filtering said captured data units according to third criteria selectable during said process and forwarding said filtered data units to a data unit analyzer.

2017017, Jun 22, 2017

Apr 17, 2015

15/304947

- Cambridge MA, US
David P. Cardin - Wilmington MA, US
Takaharu Hirayama - Kanagawa, JP
Masaaki Hirose - Tokyo, JP
Yongbo Hu - Winchester MA, US
Hiroyuki Kakei - Kanagawa, JP
Hong Myung Lee - Cambridge MA, US
Takashi Motoyaji - Kanagawa, JP
Noriyuki Nii - Kanagawa, JP
Zhan Shi - Concord MA, US
Stepan Vyskocil - Arlington MA, US
Hiroyuki Watanabe - Hyogo, JP

Millennium Pharmaceuticals, Inc. - Cambridge MA

C07D 498/04
A61K 31/498
C07D 401/14
C07D 403/14
C07D 417/14
A61K 31/541
C07D 491/107
A61K 31/5375
C07D 471/04
C07D 487/04
A61K 31/4985
C07D 413/14
C07D 401/12
C07D 491/08
A61K 31/506
C07D 409/14
A61K 31/501
A61K 31/553
C07D 405/14
C07D 417/12
A61K 31/55
C07D 491/113
C07D 403/12

This invention provides compounds of formula I and subsets thereof: wherein T, J, R, R, R, o, R, and Rand subsets thereof are as described in the specification. The compounds are inhibitors of NAMPT and are thus useful for treating cancer, inflammatory conditions, or T-cell mediated autoimmune disease.

2015021, Jul 30, 2015

Aug 2, 2013

14/419000

- Cambridge MA, US
David P. Cardin - Wilmington MA, US
Alexandra E. Gould - Cambridge MA, US
Paul D. Greenspan - Acton MA, US
Sean J. Harrison - Belmont MA, US

C07D 487/04

Disclosed are chemical entities that inhibit Uba6, each of which is a compound of Formula /: Formula (I) or a pharmaceutically acceptable salt thereof, wherein R*is —H or —CH; and Y is Formula (II) or Formula (III), wherein Ris —H, —CHor Calkyloxycarbonyl; and R, Rand Rare defined herein; pharmaceutical compositions comprising the chemical entities; and methods of using the chemical entities. These chemical entities are useful for treating disorders, particularly cell proliferation disorders, including cancers.